Global and United States Autoimmune Disease Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Immunosuppressants
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal Anti-inflammatory Drugs
1.2.6 Biologics
1.2.7 Other
1.3 Market by Application
1.3.1 Global Autoimmune Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Autoimmune Disease Therapeutics Growth Trends by Regions
2.2.1 Autoimmune Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Therapeutics Players by Market Size
3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Therapeutics Revenue
3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2019
3.5 Key Players Autoimmune Disease Therapeutics Area Served
3.6 Key Players Autoimmune Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Autoimmune Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size (2015-2026)
6.2 North America Autoimmune Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Autoimmune Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Autoimmune Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size (2015-2026)
7.2 Europe Autoimmune Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Autoimmune Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Autoimmune Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Autoimmune Disease Therapeutics Market Size (2015-2026)
8.2 China Autoimmune Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Autoimmune Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Autoimmune Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Autoimmune Disease Therapeutics Market Size (2015-2026)
9.2 Japan Autoimmune Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Autoimmune Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Autoimmune Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Autoimmune Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Autoimmune Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Autoimmune Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Autoimmune Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction
11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Autoimmune Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction
11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.3.5 Johnson & Johnson Services Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Autoimmune Disease Therapeutics Introduction
11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction
11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.5.5 Sanofi Recent Development
11.6 Abott
11.6.1 Abott Company Details
11.6.2 Abott Business Overview
11.6.3 Abott Autoimmune Disease Therapeutics Introduction
11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.6.5 Abott Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Autoimmune Disease Therapeutics Introduction
11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.8.5 Amgen Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Autoimmune Disease Therapeutics Introduction
11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.9.5 Bayer Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Eli Lilly and Company
10.11.1 Eli Lilly and Company Company Details
10.11.2 Eli Lilly and Company Business Overview
10.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction
10.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2015-2020)
10.11.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Immunosuppressants
Table 4. Key Players of Anti-Inflammatory Drugs
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 7. Key Players of Biologics
Table 8. Key Players of Other
Table 9. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Autoimmune Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Autoimmune Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Autoimmune Disease Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Autoimmune Disease Therapeutics Market Share by Regions (2021-2026)
Table 15. Autoimmune Disease Therapeutics Market Market Trends
Table 16. Autoimmune Disease Therapeutics Market Drivers
Table 17. Autoimmune Disease Therapeutics Market Challenges
Table 18. Autoimmune Disease Therapeutics Market Restraints
Table 19. Global Autoimmune Disease Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Autoimmune Disease Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2019)
Table 22. Global Autoimmune Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Autoimmune Disease Therapeutics Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 27. Global Autoimmune Disease Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Autoimmune Disease Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. Global Autoimmune Disease Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 33. North America Autoimmune Disease Therapeutics Market Share by Type (2015-2020)
Table 34. North America Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 35. North America Autoimmune Disease Therapeutics Market Share by Application (2015-2020)
Table 36. North America Autoimmune Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Autoimmune Disease Therapeutics Market Share by Country (2015-2020)
Table 38. Europe Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 39. Europe Autoimmune Disease Therapeutics Market Share by Type (2015-2020)
Table 40. Europe Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 41. Europe Autoimmune Disease Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Autoimmune Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Autoimmune Disease Therapeutics Market Share by Country (2015-2020)
Table 44. China Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 45. China Autoimmune Disease Therapeutics Market Share by Type (2015-2020)
Table 46. China Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 47. China Autoimmune Disease Therapeutics Market Share by Application (2015-2020)
Table 48. China Autoimmune Disease Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 49. China Autoimmune Disease Therapeutics Market Share by Region (2015-2020)
Table 50. Japan Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 51. Japan Autoimmune Disease Therapeutics Market Share by Type (2015-2020)
Table 52. Japan Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 53. Japan Autoimmune Disease Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Autoimmune Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 55. Japan Autoimmune Disease Therapeutics Market Share by Country (2015-2020)
Table 56. Southeast Asia Autoimmune Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 57. Southeast Asia Autoimmune Disease Therapeutics Market Share by Type (2015-2020)
Table 58. Southeast Asia Autoimmune Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 59. Southeast Asia Autoimmune Disease Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Autoimmune Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 61. Southeast Asia Autoimmune Disease Therapeutics Market Share by Country (2015-2020)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Product
Table 65. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Product
Table 70. Novartis Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 71. Novartis Recent Development
Table 72. Johnson & Johnson Services Company Details
Table 73. Johnson & Johnson Services Business Overview
Table 74. Johnson & Johnson Services Product
Table 75. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 76. Johnson & Johnson Services Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Product
Table 80. Merck Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 81. Merck Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Product
Table 85. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Abott Company Details
Table 88. Abott Business Overview
Table 89. Abott Product
Table 90. Abott Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 91. Abott Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Amgen Business Overview
Table 98. Amgen Product
Table 99. Amgen Company Details
Table 100. Amgen Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 101. Amgen Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Product
Table 105. Bayer Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 106. Bayer Recent Development
Table 107. F. Hoffmann-La Roche Company Details
Table 108. F. Hoffmann-La Roche Business Overview
Table 109. F. Hoffmann-La Roche Product
Table 110. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 111. F. Hoffmann-La Roche Recent Development
Table 112. Eli Lilly and Company Company Details
Table 113. Eli Lilly and Company Business Overview
Table 114. Eli Lilly and Company Product
Table 115. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2015-2020) (US$ Million)
Table 116. Eli Lilly and Company Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Autoimmune Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressants Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Nonsteroidal Anti-inflammatory Drugs Features
Figure 6. Biologics Features
Figure 7. Other Features
Figure 8. Global Autoimmune Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Independent Pharmacies Case Studies
Figure 12. Other Case Studies
Figure 13. Autoimmune Disease Therapeutics Report Years Considered
Figure 14. Global Autoimmune Disease Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 15. Global Autoimmune Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Autoimmune Disease Therapeutics Market Share by Regions (2021-2026)
Figure 17. Global Autoimmune Disease Therapeutics Market Share by Players in 2019
Figure 18. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2019
Figure 20. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. France Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Nordic Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Rest of Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. China Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. India Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Rest of Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 48. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 49. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 50. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 51. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 52. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 54. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 55. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed